A phase IIB,double-blind,randomized,Placebo-controlled, study assessing the efficacy of RO4607381, a CETP inhibitor, on progression or regression of carotid artery disease using Carotid MRI and FDG-PET/CT technique in patients with coronary heart disease
|Effective start/end date||3/28/08 → 3/27/11|
- HOFFMANN-LA ROCHE PHARMACEUTICALS
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.